Le. Markowitz et al., CHANGING LEVELS OF MEASLES ANTIBODY-TITERS IN WOMEN AND CHILDREN IN THE UNITED-STATES - IMPACT ON RESPONSE TO VACCINATION, Pediatrics, 97(1), 1996, pp. 53-58
Objectives. In the United States, younger women are more likely to hav
e immunity to measles from vaccination and are less likely to have bee
n exposed to the wild virus than are older women. To evaluate changes
in measles antibody titers in women in the United States and children'
s responses to measles vaccination, we analyzed data from a measles va
ccine trial. Methods. Sera collected from children before vaccination
at 6, 9, or 12 months of age and from their mothers were assayed for m
easles antibodies by plaque reduction neutralization. Responses to vac
cination with Merck Sharp & Dohme live measles virus vaccines at 9 mon
ths (Attenuvax) and 12 months (M-M-R II) were also analyzed. Results.
Among women born in the United States (n = 614), geometric mean titers
(GMTs) of measles antibodies decreased with increasing birth year. Fo
r those born before 1957, 1957 through 1963, and after 1963, GMTs were
4798, 2665, and 989, respectively. Among women born outside of the Un
ited States (n = 394), there were no differences in GMTs by year of bi
rth. Children of younger women born in the United States were less lik
ely than those of older women to be seropositive at 6, 9, or 12 months
. The response to the Vaccines varied by maternal birth year for child
ren of women born in the United States. Among 9-month-old children, 93
% of those whose mothers were born after 1963 responded, compared with
77% and 60% of those whose mothers were born in 1957 through 1963 and
before 1957, respectively. Among 12-month-old children, 98% of those
born to the youngest mothers responded, compared with 90% and 83% of t
hose whose mothers were born in 1957 through 1963 and before 1957. The
responses of children of women born outside of the United States were
not associated with maternal year of birth. Conclusions. An increasin
g proportion of children in the United States will respond to the meas
les vaccine at younger ages because of lower levels of passively acqui
red maternal measles antibodies.